[imc-winnipeg] News from the www.indymedia.org:8081 newswire

[imc-winnipeg@lists.indymedia.org]

---------------------------------------------------------------

Story from the www.indymedia.org:8081 newswire

Checkout independent media coverage of politics, protest, and life
at: http://www.indymedia.org:8081

This message was sent to you by: n

Comments: 

---------------------------------------------------------------

Article by: Nic                                          
Tuesday 22 Oct 2002
                         
Summary:MYRIAD Inc, a Utah based genetics research company threatens legal action again British Columbia and Montreal Health practitioners who test their patients for Breast Cancer Gene without paying $3,500.00+ fee...

Weblink: http://canada.com/victoria/story.asp?id=%7B0D0279FC-B2F4-48CA-9A46-6DFF52DE2173%7D

Reference at indymedia website: http://www.indymedia.org:8081//front.php3?article_id=211847

Article:
Here is the article from Canada.com and contact info for Myriad. I would LOVE anyone who knows how to hack their site.


Tuesday » October 22 » 2002
U.S. patent stops breast cancer testing
 
John Bermingham
The Province


Sunday, October 20, 2002

(Barbara) Kaminsky
 

A key breast cancer test can no longer be done in B.C. because an American company has the gene patent.

Utah-based Myriad Genetics Inc. has put a patent on two genes that can signal whether a woman may develop hereditary breast cancer.

Dr. Simon Sutcliffe, who runs the B.C. Cancer Agency, said 200 of the tests are now being routed annually to Ontario, which is ignoring the patent.

The agency used to do its own tests until the B.C. government recently ordered it to stop after legal threats by Myriad.

Myriad now wants $3,500 US for the blood test, three times what it used to cost the province.

And there\'s nothing B.C. cancer patients can do, other than paying for the test out-of-pocket.

\"The price, then, can really be held to any blackmail you wish,\" said Sutcliffe yesterday. \"Whatever they set the price at. It could be a factor of 10 or a factor of 50.\"

Myriad\'s gene patent gives it control over all research using those genes.

Barbara Kaminsky, CEO of the Canadian Cancer Society in B.C., is concerned that private companies can own genes.

\"What we\'re seeing now is the tip of the iceberg,\" she said. 

\"If this one is not dealt with, we can only, unfortunately, anticipate more to come.\"

Kaminsky is critical of the B.C. government for 

suspending the tests here while other provinces are carrying on.

\"We\'re extremely disappointed,\" she said. \"It\'s intolerable from the point of view of cancer patients.\"

She said women may have had their breasts removed needlessly because these tests were not available.

\"Now we have the tests, and to deny women access based on cost is just so inappropriate,\" she said.

About 10 per cent of cancer patients have a hereditary form of the disease.

Myriad also holds monopoly gene patents for ovarian, colon and prostate cancers, among the 99 it currently holds.

Nearly 10,000 patents relating to the human body have been filed worldwide.

Health Services Minister Colin Hansen said the genetic tests were stopped here on legal advice.

\"There is maybe merit in patenting the applications of how we use gene sequencing, but to actually patent the sequence is something I certainly have great difficulty with,\" he said.

Paying Myriad for the screenings is not going to happen, said Hansen.

\"We certainly want to make as broad a range of services available to the public. But we also have to make sure we can afford it,\" he said.

In 1998, breast cancer survivor Susan Harris of Vancouver tested negative before the genes were patented.

\"It\'s an incredibly important test, because it\'s knowledge I can share with my family,\" said the 54-year-old researcher.

She called the Myriad patent \"reprehensible.\"

\"It\'s part of a person\'s body, their being. It\'s not a machine. This precedent is very, very unsettling.\"

Email John Bermingham at: jbermingham@pacpress.southam.ca

© Copyright 2002 The Province

MYRIAD INFO:
Myriad Genetics, Inc.
320 Wakara Way
Salt Lake City, UT 84108
USA
801-584-3600 Main 
801-584-3640 Fax 

Directions to Myriad Genetics 
Myriad Patient and Healthcare Information	
1-800-469-7423
Myriad Proteomics Contact Information

Myriad Proteomics, Inc.
2150 West Dauntless Avenue (1035 North) 
Salt Lake City, Utah 84116 
801-303-1700 Main 
801-303-1701 Fax 

Comments about the Myriad.com web site should go to:
webmaster@myriad.com